Evaluation of TS and ENOSF1 Variants as a Biomarker in Response to Neoadjuvant Chemotherapy based on 5FU in Gastric Cancer Patients

OBJECTIVE: Neoadjuvant chemotherapy with 5-fluorouracil (5FU) is one of the most effective treatment options for gastric cancer patients. However, treatment response varies significantly between patients based on their genetic profile. The purpose of this study was to determine the association betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Arjmandi, Khadijeh, Ameli, Fereshteh, Salahshourifar, Iman, Esfandbod, Mohsen, Irani, Shiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810307/
https://www.ncbi.nlm.nih.gov/pubmed/36172660
http://dx.doi.org/10.31557/APJCP.2022.23.9.2983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810307/
https://www.ncbi.nlm.nih.gov/pubmed/36172660
http://dx.doi.org/10.31557/APJCP.2022.23.9.2983

Ejemplares similares